Lucy Coassin

Lucy Coassin

Private Equity Investor bij Northpond Ventures LLC

Consumer Services
Commercial Services
Health Technology

Profiel

Lucy Coassin is a Principal at Northpond Ventures.
She is a board director at Hawthorne Effect, Story Health, and Vital Biosciences, and a board observer at Vizgen.
Previously, Lucy was Head of Pharma at Current Health (a Northpond portfolio company, acquired by Best Buy).
She has 15 years of experience commercializing technology from product launch to widespread adoption.
Lucy has held business development and commercial roles at digital health and life science tool companies including Science 37 (NASDAQ: SNCE), Farcast Biosciences, Genentech, and Life Technologies (Acquired by ThermoFisher, NYSE: TMO).
Lucy received her MBA from the Stanford Graduate School of Business and a B.S.
with distinction in Chemistry from Duke University.

Actieve functies van Lucy Coassin

BedrijvenFunctieBegin
Private Equity Investor 01-03-2023
Private Equity Investor -
Private Equity Investor -
Private Equity Investor -
Alle actieve functies van Lucy Coassin

Opleiding van Lucy Coassin

Duke University Undergraduate Degree
Stanford University Masters Business Admin

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Lucy Coassin in detail bekijken

Connecties

99

Eerstegraads connecties

6

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Bedrijven in privébezit4

Commercial Services

Health Technology

Finance

Technology Services

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Lucy Coassin